V. Balasubramanian -  Ph.D Candidate, Department Of Chemistry ( Organic)

Education:

1998 – B. Pharmacy, Trivandrum Medical College, University Of Kerala, India

2000 – M.S. Pharm, Medicinal Chemistry, National Institute Of Pharm.Ed & Research [NIPER], India.

Research Experience:

2000- 2005, Research Scientist, Drug Discovery, Dr. Reddy’s Laboratories Ltd.,[RDY-NYSE], India.

Jain, R.; Balasubramanian V.; Nayyar, A. R.; Palde, P. B.; Jain, M.; Sachdeva, S.; Kaur, S.; Misra, V.; Singh, P. P.; Kaul, C. L. Ring-substituted quinolines as anti-tuberculosis agents. 2002, WO no. 628/DEL/2002.

1.      Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring- substituted quinolinecarboxamide analogues.: Monga, V; Nayyar.A; Balasubramanian, V; Prakash.. P; Sarbjit..J; Kaur.S; Singh,P.P, Jain. R; Bio-org. Med.Chem.,.12, (2004), 6465-6472..

2.      Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1: Balasubramanian, V; Amit R. Nayyar; Prakash B. Palde; Monga, V; Jain. R; Kaur.S; Singh,P.P, Bio-org. Med.Chem., 12, (2004), 4179-4188.

3.      Synthesis and Cytotoxic activity of Novel Quinazolino-b-Carboline-5-one derivatives: Baruah. B; Kavitha. D; Balasubramanian. V; Prem,K; Prashanthi, V; Sriram, R; Koteswar Rao, Y; Bio-org. Med.Chem.,12,(2004), 1991-1994.

4.      1,2-Diaryl-1-ethanone and pyrazolo[4,3-c] quinoline-4-one as novel selective cyclooxygenase-2 inhibitors: Baruah. B; Kavitha. D; Balasubramanian. V; Akhila. V; Seshagiri Rao. C; Koteswar Rao, Y; Bio-org. MedChem. Lett., 14, (2004), 445- 448.

5.      Substituted 4-Methylquinolines as a New Class of Anti-Tuberculosis Agents: Rahul Jain; Balasubramanian, V; Amit R. Nayyar; Prakash B. Palde; Bio-org. MedChem. Lett., 13, (2003), 1051-1054.

Current Projects:

Receptor Targeted Therapeutics

- Diabetes and Obesity

- Rheumatoid Arthiritis

E-mail : balan@purdue.edu